NEWS

Canada approves experimental COVID jab for 6-month-old children

Updated: July 14, 2022 at 4:58 pm EST  See Comments

Thu Jul 14, 2022 – 4:04 pm EDT

OTTAWA (LifeSiteNews) – Health Canada has just approved the first dose of Moderna’s experimental COVID-19 mRNA vaccine for children as young as six months old.  

“Health Canada has authorized the use of Moderna’s Spikevax [COVID vaccine] in children 6 months to 5 years of age. Until now, this vaccine was authorized for use in people 6 years of age or older,” Health Canada and the Public Health Agency of Canada announced on social media Thursday morning.  

(1/3) Health Canada has authorized the use of Moderna’s Spikevax #CovidVaccine in children 6 months to 5 years of age. Until now, this vaccine was authorized for use in people 6 years of age or older.https://t.co/Z2az9wes9S

— Health Canada and PHAC (@GovCanHealth) July 14, 2022

“After a thorough and independent scientific review of the evidence, the Department has determined that the vaccine is safe and effective at preventing #Covid19 in children between 6 months and 5 years of age,” added the nation’s health authorities.  

“Health Canada and the Public Health Agency of Canada will continue to closely monitor the safety of this vaccine, and will take action as necessary.” 

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors

Advertisement
1599 Geneva Bible Hardcover, The Bible of the Reformation – Enhanced, August 24, 2015
0 0 votes
Article Rating
Subscribe
Notify of
guest

0 Comments
Inline Feedbacks
View all comments
A Quick Note…

Already a subscriber? Login to remove advertisements. Not a subscriber? Join the Official Street Preachers and gain access to hundreds of presentations and exclusives that cover today's events and how they impact you, your life, and your soul. All while supporting independent Christian researchers trying to make a difference.